Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2008-11-03
2011-10-04
Gussow, Anne M. (Department: 1643)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C424S130100, C424S133100, C424S158100, C424S172100
Reexamination Certificate
active
08030469
ABSTRACT:
The present invention provides novel anti-CD26 antibodies and other, related polypeptides, as well as novel polynucleotides encoding the antibodies and polypeptides. The invention also provides methods of making the antibodies and polypeptides. Compositions and cells comprising the antibodies or polypeptides are further provided. Methods of using the antibodies and/or polypeptides, such as to inhibit cell proliferation and in the treatment of conditions associated with CD26, are also provided.
REFERENCES:
patent: 4485045 (1984-11-01), Regen
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4603112 (1986-07-01), Paoletti et al.
patent: 4676980 (1987-06-01), Segal et al.
patent: 4769330 (1988-09-01), Paoletti et al.
patent: 4777127 (1988-10-01), Suni et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4897268 (1990-01-01), Tice et al.
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5017487 (1991-05-01), Stunnenberg et al.
patent: 5047335 (1991-09-01), Paulson et al.
patent: 5075109 (1991-12-01), Tice et al.
patent: 5120642 (1992-06-01), Schlossman et al.
patent: 5219740 (1993-06-01), Miller et al.
patent: 5278299 (1994-01-01), Wong et al.
patent: 5422120 (1995-06-01), Kim
patent: 5510261 (1996-04-01), Goochee et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5565332 (1996-10-01), Hoogenboom et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5580717 (1996-12-01), Dower et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5733743 (1998-03-01), Johnson et al.
patent: 5739277 (1998-04-01), Presta et al.
patent: 5750373 (1998-05-01), Garrard et al.
patent: 5814482 (1998-09-01), Dubensky, Jr. et al.
patent: 5866692 (1999-02-01), Shitara et al.
patent: 5997867 (1999-12-01), Waldmann et al.
patent: 6054297 (2000-04-01), Carter et al.
patent: 6180377 (2001-01-01), Morgan et al.
patent: 6210671 (2001-04-01), Co
patent: 6265150 (2001-07-01), Terstappen et al.
patent: 6265551 (2001-07-01), Duke-Cohan et al.
patent: 6325989 (2001-12-01), Duke-Cohan et al.
patent: 6350861 (2002-02-01), Co et al.
patent: 6376471 (2002-04-01), Lawrence, III et al.
patent: 6413942 (2002-07-01), Felgner et al.
patent: 6436908 (2002-08-01), Koch et al.
patent: 6573096 (2003-06-01), Chen et al.
patent: 7117096 (2006-10-01), Luo et al.
patent: 7198788 (2007-04-01), Dang et al.
patent: 2002/0132979 (2002-09-01), Chen
patent: 2002/0177170 (2002-11-01), Luo et al.
patent: 2003/0022240 (2003-01-01), Luo et al.
patent: 2003/0031665 (2003-02-01), Dang et al.
patent: 2004/0010376 (2004-01-01), Luo et al.
patent: 2004/0115202 (2004-06-01), Chen
patent: 2004/0133357 (2004-07-01), Zhong et al.
patent: 2005/0084928 (2005-04-01), Birch et al.
patent: 2005/0170454 (2005-08-01), Mainwaring et al.
patent: 2006/0003405 (2006-01-01), Kallmeier et al.
patent: 2006/0093553 (2006-05-01), Dang et al.
patent: 2007/0009526 (2007-01-01), Benson et al.
patent: 2007/0037214 (2007-02-01), Luo et al.
patent: 2007/0060528 (2007-03-01), Christopher et al.
patent: 2007/0105771 (2007-05-01), Aoyagi et al.
patent: 2007/0207143 (2007-09-01), Dang et al.
patent: 2007/0259824 (2007-11-01), Morimoto et al.
patent: 0 345 242 (1989-12-01), None
patent: 0 345 242 (1989-12-01), None
patent: 0 519 596 (1992-12-01), None
patent: 0 524 968 (1993-02-01), None
patent: 0 524 968 (1993-02-01), None
patent: 0 524 968 (1993-02-01), None
patent: 2200651 (1988-08-01), None
patent: WO-89/01973 (1989-03-01), None
patent: WO-89/01973 (1989-03-01), None
patent: WO-90/07936 (1990-07-01), None
patent: WO-90/11092 (1990-10-01), None
patent: WO-91/00360 (1991-01-01), None
patent: WO-91/02805 (1991-03-01), None
patent: WO-91/07985 (1991-06-01), None
patent: WO-91/14445 (1991-10-01), None
patent: WO-92/20373 (1992-11-01), None
patent: WO-93/03769 (1993-03-01), None
patent: WO-93/06213 (1993-04-01), None
patent: WO-93/10218 (1993-05-01), None
patent: WO-93/11230 (1993-06-01), None
patent: WO-93/16102 (1993-08-01), None
patent: WO-93/19191 (1993-09-01), None
patent: WO-93/25234 (1993-12-01), None
patent: WO-93/25698 (1993-12-01), None
patent: WO-94/03622 (1994-02-01), None
patent: WO-94/04690 (1994-03-01), None
patent: WO-94/09132 (1994-04-01), None
patent: WO-94/12649 (1994-06-01), None
patent: WO-94/12649 (1994-06-01), None
patent: WO-94/23697 (1994-10-01), None
patent: WO-94-28938 (1994-12-01), None
patent: WO-95/00655 (1995-01-01), None
patent: WO-95/07944 (1995-03-01), None
patent: WO-95/11984 (1995-05-01), None
patent: WO-95/11984 (1995-05-01), None
patent: WO-95/13796 (1995-05-01), None
patent: WO-95/30763 (1995-11-01), None
patent: WO-95/30763 (1995-11-01), None
patent: WO-96/17072 (1996-06-01), None
patent: WO-96/17072 (1996-06-01), None
patent: WO-96/38550 (1996-12-01), None
patent: WO-97/42338 (1997-11-01), None
patent: WO-99/58572 (1999-11-01), None
patent: WO-01/27160 (2001-04-01), None
patent: WO-01/74299 (2001-10-01), None
patent: WO-01/74299 (2001-10-01), None
patent: WO-02/084277 (2002-10-01), None
patent: WO-02/092127 (2002-11-01), None
patent: WO-03/035696 (2003-05-01), None
patent: WO-03/035696 (2003-05-01), None
patent: WO-03/054172 (2003-07-01), None
patent: WO-03/054172 (2003-07-01), None
patent: WO-03/064630 (2003-08-01), None
patent: WO-03/064630 (2003-08-01), None
patent: WO-03/099999 (2003-12-01), None
patent: WO-03/099999 (2003-12-01), None
patent: WO-2004/009823 (2004-01-01), None
patent: WO-2004/045497 (2004-06-01), None
patent: WO-2004/045497 (2004-06-01), None
patent: WO-2004/058184 (2004-07-01), None
patent: WO-2004/058184 (2004-07-01), None
patent: WO-2005/054273 (2005-06-01), None
patent: WO-2005/054273 (2005-06-01), None
patent: WO-2005/063170 (2005-07-01), None
patent: WO-2005/063170 (2005-07-01), None
patent: WO-2007/005955 (2007-01-01), None
patent: WO-2007/014169 (2007-02-01), None
patent: WO-2007/014169 (2007-02-01), None
Skolnick and Fetrow. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotechnology, 2000. vol. 18, pp. 34-39.
Burgess, Shaheen, Ravera, Jaye, Donohue, and Winkles. Possible dissociation of the heparin binding and mitogenic activities of heparin binding (acidic fibroblast) growth factor-1 from its receptor binding activities by site directed mutagenesis of a single lysine residue. Journal of Cell Biology, 1990. vol. 111, pp. 2129-2138.
Lazar, Watanabe, Dalton, and Sporn. Transforming growth factor alpha: mutation of aspartic acid 47 and leucine 48 results in different biological activities. Molecular and Cellular Biology, 1988. vol. 8, pp. 1247-1252.
Mac Callum, Martin, and Thornton. Antibody-antigen interactions: contact analysis and binding site topography. Journal of Molecular Biology, 1996. vol. 262, pp. 732-745.
De Pascalis, Iwahashi, Tamura, Padlan, Gonzales, Santos, Giuliano, Schuck, Schlom, and Kashmiri. Grafting of abbreviated complementarity determining regions containing specificity determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody. Journal of Immunology, 2002. vol. 169, pp. 3076-3084.
Casset, Roux, Mouchet, Bes, Chardes, Granier, Mani, Pugniere, Laune, Pau, Kaczorek, and Rees. A peptide mimetic of an anti-CD4 monoclonal antibody by rational design. Biochemical and Biophysical Research Communications, 2003. vol. 307, pp. 198-205.
Vajdos, Adams, Breece, Presta, De Vos, and Sidhu. Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis. Journal of Molecular Biology, 2002. vol. 320, pp. 415-428.
Holm, Jafari, and Sundstrom. Functional mapping and single chain construction of the anti-cytokeratin 8 monoclonal antibody TS1. Molecular Immunology, 2007. vol. 44, pp. 1075-1084.
Wu, Nie, Huse, and Watkins. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues. Journal of Molecular Biology, 1999. vol. 294, pp. 151-162.
Adelman, J.P. et al. (1983). “
Aoyagi Teikichi
Hsieh Mark
Li Yan
Luo Peter Peizhi
Morimoto Chikao
Gussow Anne M.
SBI Incubation Co., Ltd.
Wenderoth Lind & Ponack LLP
LandOfFree
Anti-CD26 antibodies and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-CD26 antibodies and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-CD26 antibodies and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4271921